A detailed history of True Wealth Design, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, True Wealth Design, LLC holds 150 shares of BPMC stock, worth $13,837. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150
Previous 135 11.11%
Holding current value
$13,837
Previous $12.5 Million 4.76%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$82.48 - $101.39 $1,237 - $1,520
15 Added 11.11%
150 $13.1 Million
Q3 2024

Nov 14, 2024

BUY
$84.1 - $120.5 $11,353 - $16,267
135 New
135 $12.5 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.51B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.